To compare the effects of transjugular intrahepatic portosystemic shunt (TIPS) creation with those of endoscopic treatment with or without propranolol administration (i.e. conventional treatment) on recurrent bleeding, encephalopathy and mortality.
Two independent reviewers extracted data from each trial. For each study and type of treatment, the following data were extracted: number of patients, mean age, sex, prevalence of alcoholic cirrhosis, Child-Pugh score, presence of ascites, time between index bleeding and random assignment to treatment, type and modality of control treatment, rate of technical success of the procedures, portacaval pressure gradient before and after TIPS creation, mean length of follow-up, incidence of TIPS dysfunction, and definition and number of each outcome. Numeric discrepancies between the two independent data extractions were resolved after discussion.
Methods of synthesis
How were the studies combined? Data were extracted on the basis of the intention-to-treat principle, and treatment effects were measured as risk differences between TIPS creation and conventional treatment. For all outcomes, the pooled risk difference was computed using the methods of DerSimonian and Laird (see Other Publications of Related Interest no.2). The control treatments, variceal endoscopic sclerotherapy and banding ligation were considered as equivalent.
How were differences between studies investigated? Due to differences in clinical characteristics among study groups, varying sample sizes and different control treatments, it was assumed that heterogeneity was present even when not statistically significant and data were combined using a random-effects model. The chi-squared statistic for heterogeneity were computed and reported. In addition, sensitivity analyses were performed for type of publication (full report or abstract), and type of conventional treatment.
Results of the review
A total of 750 patients were included in 11 trials.
Quality of the trials:
The quality score for the seven trials published as full articles ranged from 51% to 88%, which was deemed to be fair or good quality.
Treatment effects:
No significant heterogeneity was found for any of the outcomes. The pooled risk difference for recurrent bleeding was -31% (95% CI, -39%, -23%) based on 750 patients in 11 trials; for encephalopathy +16% (95% CI, +10%, +22%) based on 685 patients in 10 trials; for death due to all causes +2% (95% CI, -4%, +9%) based on 750 patients in 11 trials; and for death due to bleeding -5% (95% CI, -11%, +6%) based on 593 patients in 8 trials. Clinically important complications occurred in 22% of patients and were associated with both treatments. TIPS dysfunction occurred in 55% of patients.
Sensitivity analyses:
Sensitivity analyses showed consistency of results for type of publication (full report or abstract), and type of conventional treatment (sclerotherapy, sclerotherapy plus propranolol, or endoscopic band ligation). However, the increased risk of encephalopathy after TIPS creation was not statistically significant in abstract reports, and in trials in which banding ligation was the conventional treatment.
